Patents by Inventor Christopher Robert Rovaldi

Christopher Robert Rovaldi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING MYELODYSPLASTIC SYNDROMES AND SIDEROBLASTIC ANEMIAS
    Publication number: 20210230239
    Abstract: In certain aspects, the present disclosure provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans. In some embodiments, the compositions of the disclosure may be used to treat or prevent sideroblastic anemias and myelodysplastic syndromes or one or more complications associated sideroblastic anemias and myelodysplastic syndromes.
    Type: Application
    Filed: October 1, 2020
    Publication date: July 29, 2021
    Inventors: Kenneth M. Attie, Christopher Robert Rovaldi
  • Methods for treating myelodysplastic syndromes and sideroblastic anemias
    Patent number: 10829531
    Abstract: In certain aspects, the present disclosure provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans. In some embodiments, the compositions of the disclosure may be used to treat or prevent sideroblastic anemias and myelodysplastic syndromes or one or more complications associated sideroblastic anemias and myelodysplastic syndromes.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: November 10, 2020
    Assignee: ACCELERON PHARMA INC.
    Inventors: Kenneth M. Attie, Christopher Robert Rovaldi
  • METHODS FOR TREATING MYELODYSPLASTIC SYNDROMES AND SIDEROBLASTIC ANEMIAS
    Publication number: 20190233486
    Abstract: In certain aspects, the present disclosure provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans. In some embodiments, the compositions of the disclosure may be used to treat or prevent sideroblastic anemias and myelodysplastic syndromes or one or more complications associated sideroblastic anemias and myelodysplastic syndromes.
    Type: Application
    Filed: December 5, 2018
    Publication date: August 1, 2019
    Inventors: Kenneth M. Attie, Christopher Robert Rovaldi
  • Methods for treating myelodysplastic syndromes and sideroblastic anemias
    Patent number: 10189882
    Abstract: In certain aspects, the present disclosure provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans. In some embodiments, the compositions of the disclosure may be used to treat or prevent sideroblastic anemias and myelodysplastic syndromes or one or more complications associated sideroblastic anemias and myelodysplastic syndromes.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: January 29, 2019
    Assignee: ACCELERON PHARMA INC.
    Inventors: Kenneth M. Attie, Christopher Robert Rovaldi
  • METHODS FOR TREATING MYELODYSPLASTIC SYNDROMES AND SIDEROBLASTIC ANEMIAS
    Publication number: 20160289286
    Abstract: In certain aspects, the present disclosure provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans. In some embodiments, the compositions of the disclosure may be used to treat or prevent sideroblastic anemias and myelodysplastic syndromes or one or more complications associated sideroblastic anemias and myelodysplastic syndromes.
    Type: Application
    Filed: December 3, 2015
    Publication date: October 6, 2016
    Inventors: Kenneth M. Attie, Christopher Robert Rovaldi